Impact on Safety Prescriptions: The Study of Health Care Groups Performing Pharmaceutical Interventions in Hospitalized Patients

PAMELA BERTOLDO AND MARÍA G. PARAJE

ACTA FARM. BONAERENSE

COLEGIO FARMACEUTICOS PROVINCIA DE BUENOS AIRES

Lugar: Buenos Aires; Año: 2015 vol. 34 p. 1464 - 1467

0326-2383

The clinical pharmacist interventions (CPI) are activities developed by the clinical pharmacist to take decisions in the pharmacotherapy of patients. The aim of this study is to analyze and describe the CPIs made during clinical rounds, before giving the daily dose, and to evaluate its clinical significance through the study of therapeutic groups and the impact on patients safety. This is a descriptive, prospective study. CPIs were classified as oriented to the medicine, to the medicine administration or to the physician´s prescription. A total of 450 CPIs were performed for six months with a general acceptance of 96%. The most prevalent groups of the therapeutics categories (the Anatomical Therapeutic Chemical Classification System) were (the) group "A" (59%), followed by groups ?B? (11%), ?J? (11%), (C) and (N) (7 %). The most frequently prescribed drugs were ranitidine, omeprazole and pantoprazole. Seventy-two percent of the CPIs were made suggesting the change of route of administration of the drug according to the concept of sequential therapy. This activity encourages active participation of pharmacists in interdisciplinary clinical activities.